Unibest
← Back to patent-cliff list

CAS 103-67-3

N-methyl-1-phenylmethanamineN-Benzyl-N-methylamine

Codes: IBAN-012, (IV)275500-2-a

Application context (from source-drug indications)

OsteoporosisIbandronate Sodium Hydrate/ColecalciferolOsteoporosisIbandronate Sodium HydratePostmenopausal osteoporosisIbandronate Sodium HydrateHypercalcaemiaIbandronate Sodium HydrateBone injuryIbandronate Sodium HydrateBreast cancerIbandronate Sodium HydrateMetastatic cancerIbandronate Sodium HydrateAllergic reactionEpinephrine intranasal spray (ARS Pharmaceuticals)Chronic urticariaEpinephrine intranasal spray (ARS Pharmaceuticals)UrticariaEpinephrine intranasal spray (ARS Pharmaceuticals)AsthmaEpinephrine intranasal spray (ARS Pharmaceuticals)Respiratory tract infectionEpinephrine intranasal spray (ARS Pharmaceuticals)

Source drugs (routes using this intermediate)

DrugTierExpiry
Ibandronate Sodium Hydrate/ColecalciferolTier C — Watch / trade-
Ibandronate Sodium HydrateTier C — Watch / trade-
Epinephrine intranasal spray (ARS Pharmaceuticals)Tier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.